Number of the records: 1  

Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity

  1. 1.
    0455799 - ÚMG 2016 RIV US eng J - Journal Article
    Frankum, J. - Moudrý, P. - Brough, R. - Hodný, Zdeněk - Ashworth, A. - Bártek, Jiří - Lord, C.J.
    Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity.
    OncoTarget. Roč. 6, č. 13 (2015), s. 10746-10758. ISSN 1949-2553
    R&D Projects: GA ČR GA13-17555S
    EU Projects: European Commission HEALTH-F2-2010-259893
    Grant - others:Lundbeck Foundation(DK) R93-A8990; Danish Council for Independent Research(DK) DFF-1331-00262
    Institutional support: RVO:68378050
    Keywords : DNA damage response * ubiquitin-proteasome system * RNA interference screens * PARP inhibitors * CBLC
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 5.008, year: 2015

    Permanent Link: http://hdl.handle.net/11104/0256416
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.